|
CLX Investment Company Makes Investment into Medical Innovator Zonda, Inc.
CLX Investment Company, Inc. (OTC BB: CLXN) has added to its investment portfolio a 20% interest in Zonda, Inc., an innovative medical diagnostic testing company that will launch its products in markets around the world. Zonda, which has existing revenues and some modest distribution in Europe, is preparing to expand distribution of its vastly superior, self-contained diagnostic devices for infectious diseases to professional and self-testing markets throughout Europe. Future distribution is planned in China and the United States. Beyond the critical medical applications for Zonda’s diagnostic products, the company also has bacterial and environmental surfaces testing products, which may play a critical role in identifying infectious diseases that could be harmful to millions.
Summary
CLX Investment Company is a closed-end investment fund that is providing the capital and management support
necessary to maximize the value of its portfolio companies and provide return on investment for its shareholders.
Key Investment Points
Recent one-for-three dividend confirms Company’s commitment to returning value to its shareholders
eStrategy Solutions portfolio investment is generating revenue and expanding its share of online continuing education, proctored exam and license renewal exam market
Investment in ActionView International, a publicly traded electronic advertising firm specializing in illuminated motion billboards, is funding expansion into burgeoning Asia advertising market, beginning with a project at a major airport in southern China
Investment in medical diagnostic firm, Zonda, Inc., which specializes in test products that serve the medical diagnostic and other testing markets. Patented test for infectious diseases is superior to competition and has large-scale distribution planned for European, Asian and North American markets
Future investments focused on emerging companies showing significant potential in growth markets
CLX management team is experienced in public investment fund management, investor relations, S.E.C. compliance and operations. The Company is committed to effectively managing its portfolio and rewarding investors with stock dividends wherever feasible and appropriate
For more information, please visit www.clxinvestments.com
|